SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

CAPLIN POINT LABORATORIES

BSE: 524742 20 Oct 2025
Healthcare
₹ 2064
Caplin Point Laboratories Ltd. specializes in Pharmaceuticals within the Healthcare sector.

CAPLIN POINT LABORATORIES - Share Price & Details

Market Cap
₹15,483
High /Low
2,641 / 1,551
Stock P/E
27.4
Book Value
₹375.0
Dividend Yield
0.29
ROCE
25.8
ROE
₹21.7
Face Value
2.0
PEG Ratio
1.28
EVEBITDA
₹19.2
Debt
5.02
CMP / FCF
94.5
Debt to equity
₹0.0
NP Ann
541
High price all time
2,641
Piotroski score
₹5.0
Graham Number
792.0
No. Eq. Shares
7.6
Net CF
₹59.3
Net profit
567
Price to book value
5.43
Interest Coverage
₹956.0
Low price all time
1.05
Industry PE
33.0
Reserves
₹2,835
Free Cash Flow
₹241

Broker Recommendations

Date Author Type Reco Price Target Price Potential Source PDF Link
25 Apr 2024 Asit C. Mehta Buy ₹1,357 ₹1,675 -27.5% moneycontrol View

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,2.21-0.31NA-1.250
CAPLIN POINT LABORATORIES LTD.2146.0858.91825.711.2615,48327.4
NATCO PHARMA LTD.12523.04641.011927.025.91147008.66
Rainbow Children's Medicare Li3540.33517.23347.485.091383053.7

Peer Comparison Chart


About CAPLIN POINT LABORATORIES

Caplin Point Laboratories Ltd., with Security Code 524742, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

STOCKS IN ACTION: TVS Motor, Caplin Point Laboratories, Medplus Health Services, Bharti Airtel, Vodafone Idea, Waaree Energies and others.

(27 Sep 2025)
Daily Business News Summary: Stay informed with the summary of Latest Business News from India and around the world, covering all...
Read more →

Caplin Point Laboratories Hits Day Low of Rs 2020 Amid Price Pressure

(26 Sep 2025)
Caplin Point Laboratories has faced a notable decline, with its stock dropping significantly over the past two days.
Read more →

Caplin Point Laboratories Builds Foundation for Double-digit Growth Trajectory

(20 Sep 2025)
Caplin Point Laboratories Ltd (Caplin) demonstrated exceptional performance in Q1FY25-26, delivering strong growth across key financial...
Read more →

Caplin Point Laboratories Reports Strong Financial Performance and Increased Investor Confidence

(17 Sep 2025)
Caplin Point Laboratories has recently experienced an evaluation adjustment, reflecting strong Q1 FY25-26 financial results, including net...
Read more →

Golden Crossovers: Caplin Point Lab among 4 stocks that signal further bullishness

(16 Sep 2025)
In the NSE list of stocks with a market cap of Rs 1000 crore, four stocks are witnessing Golden Crossovers, according to stockedge.com's...
Read more →

We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

(16 Sep 2025)
Key Insights Caplin Point Laboratories will host its Annual General Meeting on 22nd of September CEO Sridhar Ganesan's...
Read more →